International Stem Cell Corporation (OTCPK:ISCO) announced a private placement of an unsecured, non-convertible promissory note for gross proceeds of $600,000 on January 12, 2017. The transaction included participation from Andrey Semechkin, Chief Executive Officer of the company. The note will mature on September 1, 2017 and will carry a fixed interest rate of 3.5% per annum. The note may be pre-paid by the company without penalty at any time.